Summary Transcriptional activator interferon regulatory factor (IRF)-1 and repressor IRF-2 are known to play a critical role in the regulation of interferon (IFN) responses and oncogenesis in fibroblasts. Although these two factors are expressed in many tissues, including the brain, the role of IRFs in the central nervous system (CNS) has not been elucidated. We analysed a medulloblastoma cell line, ONS-76, as a CNSderived model system and generated its derivatives, Rl and R2 cells, which constitutively expressed each mouse IRF-1 and IRF-2 cDNA at high levels. By viral infection, Rl and R2 cells showed IFN-4 gene expression 3 h earlier than the control ONS-76 (C-76) cells, with 2.46-and 2.24-fold increase in IFN-,B production respectively. In the presence of cycloheximide, virally induced IFN-, gene expression of C-76 cells was suppressed, whereas Ri and R2 cells produced IFN-P 7.5-and 2.2-fold higher than C-76 cells respectively. On the other hand, induction of IFN-inducible genes was enhanced in Ri cells but was suppressed in R2 cells compared with C-76 cells. These results demonstrate that IRF-1 and IRF-2 may play an important role in the regulation of IFN-,B and IFN-inducible genes and that IRF-2 may have dual functions as an activator and repressor in CNS-derived cells.
Interferons (IFNs) are well-characterized cytokines that play important roles in host defence against viral infection and in regulation of cell growth and differentiation of various types of cells (Weissman and Weber, 1986; Pestka et al, 1987; Vilcek, 1990) . In the central nervous system (CNS), glia and glioma cells produce IFNs by viral infection and polyribonucleotide induction when IFNs activate IFN-inducible genes (Wong et al, 1984; Tedeschi et al, 1986 ). In addition, IFNs can enhance the excitability of cultured neurons (Calvet and Gresser, 1979) or inhibit synaptic potentiation in the tissue culture of hippocampus (D'Arcangelo et al, 1991) . Thus, IFNs manifest multiple biological activities in the CNS.
In the process of studying the mechanism of IFN responses, two nuclear factors, interferon regulatory factor-1 (IRF-1) and IRF-2, were identified and analysed (Miyamoto et al, 1988; Harada et al, 1989) . These two factors are structurally related and bind to the same regulatory cis elements within the promoters of type 1 IFN (IFN-c/p) and IFN-inducible genes (Miyamoto et al, 1988; Harada et al, 1990; Tanaka et al, 1993) . Transfection analysis with type 1 IFN cDNAs showed that IRF-I acts as a transcriptional activator in the IFN system, whereas IRF-2 acts as a repressor of IRF-1-mediated activation (Fujita et al, 1989a; Harada et al, 1990) . Recent studies using IRF-1-gene-disrupted mice have shown that IRF-1 is a critical regulator for antiviral and antibacterial functions of IFNs Kimura et al, 1994) . On the other hand, IRF-1 and IRF-2 manifest antioncogenic and oncogenic potentials, respectively, by transformation assays using NIH 3T3 cells . Furthermore, IRF-1 is regarded as a tumour suppressor from the evidence that embryonic fibroblasts lacking IRF-I are susceptible to oncogenic transformation by the activated c-Ha-ras gene alone . IRF-1 also regulates DNA damage-induced apoptosis in ras-expressing fibroblasts or mitogen-activated T lymphocytes (Tamura et al, 1995) . Thus, IRF-1 and IRF-2 function as regulators not only in IFN responses, but also in a broad range of cellular reactions.
Nevertheless, although IRF-1 is known to be expressed in the brain (Miyamoto et al, 1988) , the function of IRF-1 and IRF-2 in the CNS is not yet understood. Investigation of IRF function in the CNS may be important to understand the regulation of host defence against viral and bacterial infections and oncogenesis in the CNS. Medulloblastoma cells have been described as undifferentiated CNS-derived cells that may differentiate into neuronal and/or glial cells (Rubinstein, 1985; Valtz et al, 1991) . Previously, we have established a medulloblastoma cell line, ONS-76, with neuronal characterization in cytoskeletal proteins Yamada et al, 1989) . Here, we used this cell line to examine IRF function in the CNS because most of the neuroblastoma cell lines are derived from peripheral nervous system and other CNS-derived ones are generally established from glioma. We generated stable transfectants of ONS-76 cells overexpressing mouse IRF-1 and IRF-2 cDNA, and first analysed the well-characterized action of IRF-1 and IRF-2, i.e. regulation of IFN and IFN-inducible genes.
MATERIALS AND METHODS
Cell culture ONS-76 cells were established from a surgical specimen of cerebellar tumour, pathologically diagnosed as medulloblastoma, from a 2-year-old girl using the primary explant technique . The cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and 4 mm glutamate at 37°C in 5% carbon dioxide. The cells were detached from culture dishes with *Present address: Department of Immunology, Medical School of Tokyo University, Hongo 7-3-1, Bunkyo-ku, Tokyo 113, Japan 0.05% trypsin and 0.02% EDTA and were replated for expansion. The cells at 33-36 passages were used for the present study.
Detection of IFN-f production
For production of IFN-P, poly(I):poly(C) (Dako) was added to monolayer cells at the concentration of 100 tg ml in the presence of DEAE-dextran (500 ,ug ml-') for 1 h in phosphate buffer solution (PBS). Six hours after the treatment with poly(I):poly(C), the supernatants were harvested for determination of IFN yield. Virus induction was performed by infection with Newcastle disease virus (NDV), as previously described (Fujita and Kohno, 1981) . The concentrations of IFN-3 in supernatants were determined in enzyme-linked immunosorbent assay (ELISA) kits (Toray-Fuji Bionics, Tokyo, Japan). The microtitre plates were coated with a murine monoclonal antibody to human IFN-f. The standard contained recombinant human IFN-P (Toray). Samples of supernatants were pipetted into the wells. After washing, an enzymelinked murine monoclonal antibody specific for human IFN-4 (Dako) was added. After washing to remove unbound antibody-enzyme reagent, a substrate solution was added. Colour developed in proportion to the concentration of IFN-3 bound in the initial step. Absorbency at 450 nm was measured using an ELISA reader. For IFN stimulation, recombinant human IFN-3 (Toray, Tokyo) was added to the culture media at the concentration of 3x 102or3x l0-Umlrn.
Retrovirus-mediated gene transfer and selection of stable transfectants
Recombinant retroviruses pGDIRFl and pGDIRF2 were described previously . To obtain cell clones overexpressing IRF-1 or IRF-2, ONS-76 cells were transfected by recombinant retrovirus pGDIRF-1, pGDIRF-2 or pGD as control [multiplicity of infection (MOI) 10] with 8 [tg ml' polybrene to culture media. After 94-h inoculation, the culture media containing retrovirus were removed and ONS-76 cells were cultured for 2 days, then followed by 600,g ml-' G418 (neomycin; Gibco, Grand Island, NY, USA) selection for 2 weeks. More than 105 clones were obtained after transfection of pGDIRF-1 (R1), pGDIRF-2 (R2) and pGD (C-76) . Expression of the IRF-1 and IRF-2 mRNAs and protein contents in these transfectants were confirmed by Northern blot and gel-shift analysis.
Northern blot analysis
Cells were washed twice with PBS and total RNA was extracted (Harada et al, 1990) . Northern blot analysis was carried out according to the method of Church and Gilbert (1984) . To prepare probes, the following DNAs were labelled by the multiprime DNA labelling reaction (Amersham): mouse IRF-1, a 1.8-kb EcoRI fragment from L28-8 (Miyamoto et al, 1988) ; human IRF-1, a 0.65-kb NcoI-KpnI fragments of pHIRF-31 ; mouse IRF-2, a 1.4-kb XbaI fragment from pIRF2-5 ; human IRF-2, a 1.4-kb XbaI fragment from pHIRF4S-51 (Itoh et al, 1989) ; and human IFN-f probe is the same as described previously (Miyamoto et al, 1988) . 2'-5' oligoadenylate (2-5 A) synthetase, a 1.3-kb BamHI fragment from pE22-1 (Shiojiri et al, 1986) was kindly provided by Dr Y Sokawa, Kyoto Institute of Technology. Specific activities of all of the probes were similar. (l):poly(C) (100,g ml-') in the presence of DEAE-dextran (500 mg ml-') for 1 h. Six hours after the treatment with poly(l):poly(C), the supernatants were harvested for determination of IFN yields. 
Gel-shift analysis
Cells were suspended in lysis buffer (20 mm Hepes, pH 7.9; 50 mm sodium chloride; 10 mm EDTA; 2 mM EGTA; 10 mM sodium molybdate; 10 mm sodium orthovanadate; 100 mm sodium fluoride; 0.1% NP40; 0.5 mm phenylmethylsulphonyl flouride (PMSF); 100 tg ml-' leupeptin). The suspensions were sonicated for 2 min and centrifuged at 12 000 r.p.m. for 10 min. The supernatant was used as cell extract. Then, gel-shift assays were performed as follows. Two microlitres of the partially purified antibodies (anti-IRF-l, 5.5 mg ml-'; anti-IRF-2, 5.5 mg ml-') and 20 mg of protein from the cell extracts were incubated on ice for 60 min. 32P-labelled Cl oligomer (4 fml, 3000 c.p.m. fmol-') (Harada et al, 1990) , 1 mg of herring sperm DNA, and 2 mg of poly (I): poly(C) were then added and incubated at 25°C for 60 min in a final volume of 10 ml containing 10 mm Tris-HCl (pH 7.5), 50 mm sodium chloride, 1 mM dithiothreitol (DTT), 1 mM EDTA and 5% glycerol. Electrophoresis was performed as described previously (Harada et al, 1990 ).
Flow cytometric analysis Cells were grown to confluence in 25-cm2 plastic flasks and treated with IFN-1 (300 or 3000 U ml') for 24 h. Cells were harvested by vigorous pipetting and were resuspended in ice-cold buffer (PBS with 5% FBS and 0.5% sodium azide). The cells were NDV for 1 h. Five micrograms of total RNA isolated from cells at several time intervals after each induction were subjected to Northern blot analysis. The filters were stained with methylene blue to show 28S ribosomal RNA and then probed with IRF-1 or IRF-2 incubated with 1:1000 diluted monoclonal antibody against MHC class I antigens (Bio-Rad, Richmond, CA, USA) for 30 min at 40C and then washed three times with the buffer. The cells were then incubated in a 1: 100 dilution of goat anti-mouse IgG conjugated to fluorescein isothiocyanate (Sigma, St Louis, MO, USA) in the buffer for 30 min at 4°C. Thereafter, the cells were washed three times in ice-cold PBS and analysed on an EPICS Elite flow cytometer (Coulter, Hlaleah, FL, USA).
RESULTS

Induction of IRF-1 and IRF-2 mRNAs in ONS-76 cells
To examine the induction of IRF-1 and IRF-2 genes in CNSderived cells, ONS-76 cells were incubated for different time periods after IFN-,B stimulation or viral infection, and levels of IRF-1 and IRF-2 mRNA were determined by Northern blot analysis. As shown in Figure IA , after IFN-4 stimulation a rapid increase for IRF-1 and IRF-2 mRNA was observed, with maximum inductions at 6 h for IRF-1 and 3 h for IRF-2. This result differed from the previous reports of fibroblasts in which IRF-1 was induced very quickly after IFN-3 stimulation (Fujita et al, 1989b; Harada et al, 1989; Reis et al, 1992) . Under NDV infection, IRF-1 and IRF-2 genes were induced more slowly than under S IFN-1 stimulation, and both induction levels peaked at 9 h after infection as shown in Figure lB . This evidence was in agreement with the previous reports of fibroblasts (Fujita et al, 1989b; Harada et al, 1989; Reis et al, 1992 Figure 2A ). We used C-76 cells (mixture of no inducing clones) as control. Then, we analysed IRF-1 or IRF-2 expression for protein level by gel-shift analysis.
As shown in Figure 2B , there were two bands of IRF-1 and IRF-2, in agreement with the results in fibroblasts 1990) . The DNA-binding activity of IRF-1 in RI cells was 7.3-fold and that of IRF-2 in R2 cells was 8.2-fold higher than C-76 cells when analysed using a densitometer (Fuji film, Tokyo, Japan). In this study, we detected a slower migrating band reactive to anti IRF-2 antibody that was not detected in fibroblasts ( Figure  2B ). There was no alternation in cell growth, morphology and cytoskeletal protein markers among parental ONS-76, C-76, R1 and R2 cells (data not shown).
IFN-P production and expression of IFN-,B gene in Rl and R2 cells
Without or with IFN-P stimulation, there were no detectable levels of IFN-P production in C-76, RI and R2 cells using ELISA (Table 1) .
No detectable production of IFN-f in RI cells after IFN treatment was in agreement with results in stable transfectants overexpressing IRF-1 derived from other cell types (Leblanc et al, 1990; Reis et al, 1992) . Under viral induction, RI and R2 cells produced 2.46-and 2.24-fold higher IFN-f than C-76 cells, and under poly(I): poly(C) stimulation after IFN-P priming, RI and R2 cells produced 2.33-and 1.87-fold higher IFN-P than C-76 cells respectively (Table 1) . To examine whether overexpression of IRF-1 or IRF-2 affects IFN-1 production at transcriptional levels, total RNA extracted from C-76, RI and R2 cells every 3 h after viral infection were subjected to Northern blot analysis ( Figure 3A ). The induction of the IFN-, gene in both RI and R2 cells was detected 3 h earlier than that of C-76 cells, and the rate of decrease after maximal induction was slower in R1 and R2 cells than in C-76 cells using densitometric measurement ( Figure 3B ). However, there was no significant difference in the magnitude of maximal induction in C-76, RI and R2 cells ( Figure  3B ). These results indicate that not only IRF-1 but also IRF-2 overexpression in ONS-76 cells up-regulated the expression of the IFN-3 gene by viral infection or double-stranded RNA stimulation. 
Regulation of IFN-inducible genes in Rl and R2 cells
The possible roles of IRF-l and IRF-2 in the transcriptional regulation of IFN-inducible genes were extensively analysed Watanabe et al, 1991; Matsuyama et al, 1993) . Among the IFN-inducible genes known to contain IRF-binding domains in their promoter regions are the genes for 2-5 A synthetase and MHC class I antigens. Constitutive expression of IRF-1 mRNA in the sense or antisense orientation in human fibroblasts (GM637) demonstrated enhancement or suppression of the expression of IFN-inducible genes respectively (Reis et al, 1992) . In this study, by using stable transfectants overexpressing IRF-1 or IRF-2 mRNA, we found a reciprocal role of IRF-1 and IRF-2 in the regulation of the expression of these genes. The levels of 2-5 A synthetase mRNA were determined by Northern blot analysis after C-76, RI and R2 cells were exposed for different time periods to IFN-3. As shown in Figure SA , three bands, 3.6, 3.2 and 1.6-1.8 kb, that hybridized to the probe appeared in ONS-76 cells as well as other human cell lines (Hovanessian, 1991) . Induction of 2-5 A synthetase mRNA by IFN-was observed earlier in RI cells than in C-76 cells, whereas it was lower in R2 cells than in C-76 cells at all time periods. The kinetics of mRNA induction in R 1 cells exhibited the maximum at 6 h and then a gradual decrease; in contrast, that of C-76 and R2 cells increased more slowly ( Figure SB) . On the other hand, C-76, RI and R2 cells were treated for 24 h with 300 or 3000 U ml-' of IFN-P, and the cell-surface expression of MHC class I antigens by IFN-f was measured using flow cytometric analysis ( Figure 6 ). Without IFN-P treatment, expression of MHC class I antigens was higher in R1 cells and lower in R2 cells than in C-76 cells (Table 2) . With 300 U ml-' IFN-P treatment, expression of MHC class I antigen was elevated in C-76 or in RI cells compared with that of the respective uninduced cells, whereas R2 cells had no significant change in the fold induction. In the presence of 3000 U mll of IFN-3, which was more markedly elevated in all the type of cells than in the case of 300 U ml IFN-3, RI cells increased 3. (Figure 1 ) and the slower migrating band reactive anti-IRF-2 antibody ( Figure 2B ) were newly observed in our model system (Harada et al, 1990; Reis et al, 1992) . Further investigation will be necessary to examine whether these phenomena are unique to CNS-derived cells. As mentioned in previous reports (Fujita et al, 1989a; Harada et al, 1990; (Figure 4) implied that IRF-2 may directly convert to an activator. From our present study, it is still unclear whether the activation of the IFN-f gene by IRF-2 is only limited in CNS-derived cells. On the other hand, the human histone H4 gene F0108 has been shown to be activated by IRF-2 by using cDNA overexpression study (Vaughan et al, 1995 (Yamamoto et al, 1994) .
(2) It has been observed that the IFN-P gene expression is inhibited by a protein kinase inhibitor, 2-aminopurine (Zinn et al, 1988 In our study, gel-shift assay showed a slower migrating band that was not detected in fibroblasts ( Figure 2B) (Watanabe et al, 1991 (Figures 5 and 6 ). These results agreed with previous reports (Fujita et al, 1989a; Harada et al, 1990; Reis et al, 1992; Matsuyama et al, 1993) . However, as shown in Figure  5A and B, 2-5 A synthetase induction by IFN stimulation in RI cells decreased after the maximum. This suppression was a novel finding in our model system. On the other hand, embryonic fibroblasts from mice with a null mutation in the IRF-1 gene showed no significant changes in the induction of IFN-inducible genes, such as 2-5 A synthetase or double-stranded RNA-dependent protein kinase under IFN stimulation . This evidence demonstrates the existence of IRF-I independent pathway in the expression of IFN-inducible genes. In fact, IFN-inducible genes are known to be activated by a family of ISGF-3 (IFN-stimulated gene factor-3) including Stat (signal transducer and activator of transcription) proteins (Darnell et al, 1994) . Many cytokines, including IFNs, exhibit a wide range of biological effects in various tissues and cells, whereas different cytokines can act on the same cells type to mediate similar effects (Weissmann and Weber, 1986; Vilcek, 1990) . This functional pleiotropy and redundancy may be explained in part by the existence of diverse and shared transcription factors in cytokine signalling. Thus, we have been much concerned with the involvement of other transcriptional factors such as ISGF-3 in IFN-inducible gene expression in CNS because IFNs exhibit specific effects on neuronal cells (Calvet and Gresser, 1979; D'Arcangelo et al, 1991) and other transcriptional factors may provide a clue to a mechanism for the suppression of 2-5 A synthetase after the maximal induction ( Figure 5B ).
It has been identified that IRF-1 functions as a tumour suppressor Tanaka et al, 1994) , and that IRF-I regulates critical target genes that regulate cell cycle and apoptosis : Tamura et al, 1995 . This notion is also supported by the fact that deletion of one or both alleles of the IRF-1 gene was observed in many human leukaemia, myelodysplasia and oesophageal carcinomas (Willman et al, 1993; Ogasawara et al, 1996) , and that functional loss of IRF-I by aberrant exon skipping was observed in myelodysplasia . In our study, we found that IRF-I and IRF-2 may regulate IFN responses in CNS but that overexpression of IRF-1 and IRF-2 did not effect upon cell growth and phenotypes of ONS-76 cell line (data not shown). However, it will be interesting to analyse the role of IRF-I and IRF-2 in oncogenesis of CNS-derived cells such as medulloblastoma or glioblastoma and to investigate critical target genes of IRF-1 and IRF-2 in CNS in the near future.
